ZEMURON SOLUTION

מדינה: קנדה

שפה: אנגלית

מקור: Health Canada

מרכיב פעיל:

ROCURONIUM BROMIDE

זמין מ:

MERCK CANADA INC

קוד ATC:

M03AC09

INN (שם בינלאומי):

ROCURONIUM BROMIDE

כמות:

10MG

טופס פרצבטיות:

SOLUTION

הרכב:

ROCURONIUM BROMIDE 10MG

מסלול נתינה (של תרופות):

INTRAVENOUS

יחידות באריזה:

10X5ML

סוג מרשם:

Prescription

איזור תרפויטי:

NEUROMUSCULAR BLOCKING AGENTS

leaflet_short:

Active ingredient group (AIG) number: 0126317001; AHFS:

מצב אישור:

CANCELLED POST MARKET

תאריך אישור:

2018-02-05

מאפייני מוצר

_ _
_Page 1 of 35_
PRODUCT MONOGRAPH
ZEMURON
®
Rocuronium Bromide
10 mg/mL Solution for Injection
_ _
Non-depolarizing Skeletal Neuromuscular Blocking Agent
MERCK CANADA INC.
Date of Revision:
16750 route Transcanadienne
November 5, 2018
Kirkland, QC Canada H9H 4M7
www.merck.ca
Submission Control No: 220017
_ _
_ _
_ _
_ _
_Page 2 of 35_
_ _
TABLE OF CONTENTS
[To create the table of contents, select from the
PART I: HEALTH PROFESSIONAL INFORMATION
..........................................................3
SUMMARY PRODUCT INFORMATION
...............................................................................
3
INDICATIONS AND CLINICAL USE
.....................................................................................
3
CONTRAINDICATIONS
..........................................................................................................
4
WARNINGS AND PRECAUTIONS
.........................................................................................
4
ADVERSE REACTIONS
...........................................................................................................
8
DRUG INTERACTIONS
.........................................................................................................
12
DOSAGE AND ADMINISTRATION
.....................................................................................
13
OVERDOSAGE
.......................................................................................................................
18
ACTION AND CLINICAL PHARMACOLOGY
................................................................... 18
STORAGE AND STABILITY
.................................................................................................
26
SPECIAL HANDLING INSTRUCTIONS
..............................................................................
26
DOSAGE FORMS, COMPOSITION AND PACKAGING
.................................................... 26
PART II: SCIENTIFIC INFORMATION
...............................................................................28
PHARMACEUTI